Abbott India Q2 PAT seen up 4.7% to Rs 77.5 cr: Centrum

Net Sales are expected to increase by 2 percent Q-o-Q (up 16.7 percent Y-o-Y) to Rs 752.5 crore, according to Centrum.

October 19, 2016 / 14:34 IST

live

bselive
nselive

Volume

Todays L/H

Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Abbott India to report net profit at Rs 77.5 crore, up 4.7 percent quarter-on-quarter.Net Sales are expected to increase by 2 percent Q-o-Q (up 16.7 percent Y-o-Y) to Rs 752.5 crore, according to Centrum.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 2.4 percent Q-o-Q (up 25.2 percent Y-o-Y) to Rs 108 crore.

Centrum's report on Abbott India

We expect the company to report superior performance, driven by its strong brands, new product launches and marketing thrust.

AIL has launched 17 new products in FY16 and these are likely to drive future growth.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

first published: Oct 19, 2016 02:34 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347